2-(2-Methylphenyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-amine, 95.0%, 500mg

Ethyl 2-(2,5-dichlorophenyl)sulfanylacetate, 1g

(4,6-Dichloropyridin-2-yl)methanol, 97.0%, 5g

2-(2-methoxyphenyl)piperazine, 95.0%, 100mg

trans-3,5-Bis(trifluoromethyl)cinnamic acid, 98%, 5g

n-(5-Bromopyridin-2-yl)-4-methylbenzenesulfonamide, 97%, 25g

ETHYL 6-CHLORO-4-(CYCLOPROPYLAMINO)NICOTINATE, 95%, 1g

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.001 g, 220 g, BCE223-1S (W)

3,5-Dichloronitrobenzene>99.0%(GC)25g

ethyl 4-amino-1H-pyrazole-5-carboxylate, 95%, 25g

3-(Dimethylamino)-1-phenyl-2-propen-1-one>98.0%(GC)(T)5g

2-Methyl[1,3]oxazolo[4,5-b]pyridine, 97.0%, 100mg

N-Benzyl-2-oxocyclopentane-1-carboxamide, 97%, 5g